SARS-CoV-2 Rapid Antigen Test Nasal

SARS-CoV-2 Rapid Antigen Test Nasal

Product Code: 09445323077

SARS-CoV-2 Rapid Antigen Test Nasal

  • Rapid chromatographic immunoassay for the qualitative detection of the nucleocapsid protein of SARS-CoV-2 present in human nasal specimens
  • In clinical studies, the SARS-CoV-2 Rapid Antigen Test Nasal showed a relative sensitivity of 90.6% (Ct value ≤ 30; 95 % CI: 75.0 % – 98.0 %) and a specificity of 98.6% for professionally collected samples
  • For self-collected samples, a sensitivity of 84.4 % (Ct value ≤ 30; 95 % CI: 67.2 % – 94.7 %) and a specificity of 99.2% was detected
  • Overall, the studies contained 468 symptomatic and asymptomatic individuals
  • Test is intended to detect antigen from SARS-CoV-2 in individuals suspected of COVID-19 or with known or suspected exposure to SARS-CoV-2
Category Covid-19 Tests

Specifications

Brand

Own Brand

Categories

Infection Control

Category

COVID-19 Tests

Product Highlights

Description

SARS-CoV-2 Rapid Antigen Test Nasal

  • Rapid chromatographic immunoassay for the qualitative detection of the nucleocapsid protein of SARS-CoV-2 present in human nasal specimens
  • In clinical studies, the SARS-CoV-2 Rapid Antigen Test Nasal showed a relative sensitivity of 90.6% (Ct value ≤ 30; 95 % CI: 75.0 % – 98.0 %) and a specificity of 98.6% for professionally collected samples
  • For self-collected samples, a sensitivity of 84.4 % (Ct value ≤ 30; 95 % CI: 67.2 % – 94.7 %) and a specificity of 99.2% was detected
  • Overall, the studies contained 468 symptomatic and asymptomatic individuals
  • Test is intended to detect antigen from SARS-CoV-2 in individuals suspected of COVID-19 or with known or suspected exposure to SARS-CoV-2
SARS-CoV-2 Rapid Antigen Test Nasal

SARS-CoV-2 Rapid Antigen Test Nasal

Product Code: 09445323077

SARS-CoV-2 Rapid Antigen Test Nasal

  • Rapid chromatographic immunoassay for the qualitative detection of the nucleocapsid protein of SARS-CoV-2 present in human nasal specimens
  • In clinical studies, the SARS-CoV-2 Rapid Antigen Test Nasal showed a relative sensitivity of 90.6% (Ct value ≤ 30; 95 % CI: 75.0 % – 98.0 %) and a specificity of 98.6% for professionally collected samples
  • For self-collected samples, a sensitivity of 84.4 % (Ct value ≤ 30; 95 % CI: 67.2 % – 94.7 %) and a specificity of 99.2% was detected
  • Overall, the studies contained 468 symptomatic and asymptomatic individuals
  • Test is intended to detect antigen from SARS-CoV-2 in individuals suspected of COVID-19 or with known or suspected exposure to SARS-CoV-2
Category Covid-19 Tests

Specifications

Brand

Own Brand

Categories

Infection Control

Category

COVID-19 Tests

Product Highlights

Description

SARS-CoV-2 Rapid Antigen Test Nasal

  • Rapid chromatographic immunoassay for the qualitative detection of the nucleocapsid protein of SARS-CoV-2 present in human nasal specimens
  • In clinical studies, the SARS-CoV-2 Rapid Antigen Test Nasal showed a relative sensitivity of 90.6% (Ct value ≤ 30; 95 % CI: 75.0 % – 98.0 %) and a specificity of 98.6% for professionally collected samples
  • For self-collected samples, a sensitivity of 84.4 % (Ct value ≤ 30; 95 % CI: 67.2 % – 94.7 %) and a specificity of 99.2% was detected
  • Overall, the studies contained 468 symptomatic and asymptomatic individuals
  • Test is intended to detect antigen from SARS-CoV-2 in individuals suspected of COVID-19 or with known or suspected exposure to SARS-CoV-2

Still curious about the benefits of a Codex account?

Talk to Expert
SEARCH ×